Symrise reported strong demand in both segments and all regions and increased sales by 23% (18% at local currency) to €2,601.7 million (US$2,854.90 million; 2014: €2,120.1 million).
EBITDA showed strong growth and rose by 23% to € 572.2 million (normalized EBITDA in 2014: €464.5 million).
The EBITDA margin increased to 22.0% (2014 normalized: 21.9%).
“In 2015 it was our decisive goal to substantially grow our business. We made targeted investments in growth and in expanding our competencies and know-how,” said CEO Dr. Heinz-Jürgen Bertram.
“Our portfolio has expanded beyond our traditional product range and allows us to serve new, strategic business areas such as functional ingredients for everyday products.
“A priority for us in 2016 is the cross-linking of our extensive expertise,” he added.
“In this way we will not only continue on track for success but also extend our competitive edge with a widely diversified portfolio.”
Double-digit sales growth in all regions
Symrise benefited in the year under review from high capacity utilization and strong demand in all regions.
Sales increased to €2,601.7 million (2014: €2,120.1 million).
This represents growth of 23 % in reporting currency and 18 % at local currency.
The Diana Group, which was acquired in mid-2014 and is now fully integrated, contributed sales of €524.8 million (2014: €233.9 million).
Excluding the contribution of Diana, Symrise also generated strong sales growth with 10% in reporting currency and 6% at local currency.
Above-average growth in emerging markets
In the emerging markets, the Group increased its sales by 21% (local currency) and generated 46% of its total sales (2014: 47%).
The decrease as compared to the previous year reflects the regional sales mix of the Diana Group, which generates a higher sales proportion in Developed Markets.
Flavor & Nutrition experienced a substantial 34% increase in sales (31% at local currency) and benefited in particular from strong demand for beverages and savory applications.
Diana Group also achieved strong growth, especially with pet food and aquaculture applications. Excluding Diana, sales increased by 11% (8% at local currency).
EBITDA in this segment staged by 41% to €340.9 million (2014 normalized: €241.6 million).
The EBITDA margin rose to 22.3% (2014 normalized: 21.2%).
